The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review

Journal of Autoimmunity

Volumn 48-49, Issue , 2014, Pages 134-142

  Karussis, Dimitrios ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Biomarkers; Clinically isolated syndrome (CIS); Diagnostic criteria; Multiple sclerosis (MS); Neuromyelitis optica (NMO); Radiologically isolated syndrome (RIS)

Indexed keywords

BIOLOGICAL MARKER;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ACUTE HEMORRHAGIC LEUKOENCEPHALITIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BALO CONCENTRIC SCLEROSIS; CEREBROSPINAL FLUID ANALYSIS; DEMYELINATING DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISABILITY; DISEASE COURSE; HUMAN; IMMUNOPATHOGENESIS; MARBURG HEMORRHAGIC FEVER; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSIS; RADIOLOGICALLY ISOLATED SYNDROME; REVIEW; SCHILDER DISEASE;

BIOMARKERS; CLINICALLY ISOLATED SYNDROME (CIS); DIAGNOSTIC CRITERIA; MULTIPLE SCLEROSIS (MS); NEUROMYELITIS OPTICA (NMO); RADIOLOGICALLY ISOLATED SYNDROME (RIS);

BIOLOGICAL MARKERS; BRAIN CHEMISTRY; DEMYELINATING DISEASES; GENETIC VARIATION; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PREDICTIVE VALUE OF TESTS; RISK; SPINAL CORD; SYNDROME;

EID: 84895894740     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.01.022     Document Type: Review

References (134)

1. Compston A., Coles A. Multiple sclerosis. Lancet 2008 Oct 25, 372(9648):1502-1517. PubMed PMID: 18970977. Epub 2008/10/31. eng.
2. Frohman E.M., Racke M.K., Raine C.S. Multiple sclerosis-the plaque and its pathogenesis. NEngl J Med 2006 Mar 2, 354(9):942-955. PubMed PMID: 16510748. Epub 2006/03/03. eng.
3. Steinman L. Multiple sclerosis: a two-stage disease. Nat Immunol 2001 Sep, 2(9):762-764. PubMed PMID: 11526378. Epub 2001/08/30. eng.
4. Kingwell E., Marriott J.J., Jette N., Pringsheim T., Makhani N., Morrow S.A., et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol 2013 Sep 26, 13(1):128. PubMed PMID: 24070256. Epub 2013/09/28. Eng.
5. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. NEngl J Med 1998 Jan 29, 338(5):278-285. PubMed PMID: 9445407. Epub 1998/01/29. eng.
6. Allegretta M., Nicklas J.A., Sriram S., Albertini R.J. Tcells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990 Feb 9, 247(4943):718-721. PubMed PMID: 1689076. Epub 1990/02/09. eng.
7. Zhang J., Markovic-Plese S., Lacet B., Raus J., Weiner H.L., Hafler D.A. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. JExp Med 1994 Mar 1, 179(3):973-984. PubMed PMID: 7509366. Pubmed Central PMCID: 2191414. Epub 1994/03/01. eng.
8. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995, 80(7534214):695-705.
9. Venken K., Hellings N., Hensen K., Rummens J.L., Stinissen P. Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens. JNeuroimmunol 2010 Sep 14, 226(1-2):185-191. PubMed PMID: 20554330. Epub 2010/06/18. eng.
10. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000 Jun, 47(6):707-717. PubMed PMID: 10852536. Epub 2000/06/14. eng.
11. Cepok S., Rosche B., Grummel V., Vogel F., Zhou D., Sayn J., et al. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005 Jul, 128(Pt 7):1667-1676. PubMed PMID: 15800022. Epub 2005/04/01. eng.
12. Owens G.P., Bennett J.L., Gilden D.H., Burgoon M.P. The B cell response in multiple sclerosis. Neurol Res 2006 Apr, 28(3):236-244. PubMed PMID: 16687047. Epub 2006/05/12. eng.
13. Archelos J.J., Storch M.K., Hartung H.P. The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol 2000 Jun, 47(6):694-706. PubMed PMID: 10852535. Epub 2000/06/14. eng.
14. Prineas J.W., Graham J.S. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann Neurol 1981 Aug, 10(2):149-158. PubMed PMID: 7025748. Epub 1981/08/01. eng.
15. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Puopolo M., et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007 Apr, 130(Pt 4):1089-1104. PubMed PMID: 17438020. Epub 2007/04/18. eng.
16. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004 Apr, 14(2):164-174. PubMed PMID: 15193029. Epub 2004/06/15. eng.
17. Zettl U.K., Stuve O., Patejdl R. Immune-mediated CNS diseases: a review on nosological classification and clinical features. Autoimmun Rev 2012, 11(21619943):167-173.
18. Okuda D.T., Mowry E.M., Beheshtian A., Waubant E., Baranzini S.E., Goodin D.S., et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 2009 Mar 3, 72(9):800-805. PubMed PMID: 19073949. Epub 2008/12/17. eng.
19. Miller D., Barkhof F., Montalban X., Thompson A., Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management. Lancet Neurol 2005 Jun, 4(6):341-348. PubMed PMID: 15907738. Epub 2005/05/24. eng.
20. Miller D., Barkhof F., Montalban X., Thompson A., Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005 May, 4(5):281-288. PubMed PMID: 15847841. Epub 2005/04/26. eng.
21. Brinar V.V., Habek M. Diagnostic imaging in acute disseminated encephalomyelitis. Expert Rev Neurother 2010, 10(20187866):459-467.
22. Menge T., Kieseier B.C., Nessler S., Hemmer B., Hartung H.-P., Stuve O. Acute disseminated encephalomyelitis: an acute hit against the brain. Curr Opin Neurol 2007, 20(17495616):247-254.
23. Kuperan S., Ostrow P., Landi M.K., Bakshi R. Acute hemorrhagic leukoencephalitis vs ADEM: FLAIR MRI and neuropathology findings. Neurology 2003, 60(12601124):721-722.
24. Mader I., Wolff M., Niemann G., Kuker W. Acute haemorrhagic encephalomyelitis (AHEM): MRI findings. Neuropediatrics 2004, 35(15127316):143-146.
25. Susac J.O., Daroff R.B. Magnetic resonance images on Marburg variant. JNeuroimaging 2005, 15(15746237):206.
26. Poser C.M., Goutieres F., Carpentier M.A., Aicardi J. Schilder's myelinoclastic diffuse sclerosis. Pediatrics 1986, 77(3940347):107-112.
27. Wingerchuk D.M., Weinshenker B.G. Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica. Contin (Minneap Minn) 2013 Aug, 19(4 Multiple Sclerosis):944-967. PubMed PMID: 23917095. Epub 2013/08/07. eng.
28. Lucchinetti C.F., Gavrilova R.H., Metz I., Parisi J.E., Scheithauer B.W., Weigand S., et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 2008 Jul, 131(Pt 7):1759-1775. PubMed PMID: 18535080. Pubmed Central PMCID: 2442427. Epub 2008/06/07. eng.
29. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006 May 23, 66(10):1485-1489. PubMed PMID: 16717206. Epub 2006/05/24. eng.
30. Wingerchuk D.M. Neuromyelitis optica spectrum disorders. Contin (Minneap Minn) 2010 Oct, 16(5 Multiple Sclerosis):105-121. PubMed PMID: 22810601. Epub 2010/10/01. eng.
31. McKeon A., Fryer J.P., Apiwattanakul M., Lennon V.A., Hinson S.R., Kryzer T.J., et al. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol 2009 Sep, 66(9):1134-1138. PubMed PMID: 19752303. Epub 2009/09/16. eng.
32. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol 2007 Sep, 6(9):805-815. PubMed PMID: 17706564. Epub 2007/08/21. eng.
33. Bomprezzi R., Powers J.M., Shimizu J., Tsuji S., Weinshenker B.G., Wingerchuk D.M. IFNbeta-1b may severely exacerbate Japanese opticspinal MS in neuromyelitis optica spectrum: Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment?. Neurology 2011 Jul 12, 77(2):195. discussion -6. PubMed PMID: 21747078. Epub 2011/07/13. eng.
34. Schumacker G.A., Beebe G., Kibler R.F., Kurland L.T., Kurtzke J.F., McDowell F., et al. Problems of Experimental Trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965 Mar, 31(122):552-568. PubMed PMID: 14313512. Epub 1965/03/31. eng.
35. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 Mar, 13(3):227-231. PubMed PMID: 6847134. Epub 1983/03/01. eng.
36. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 Jul, 50(1):121-127. PubMed PMID: 11456302. Epub 2001/07/18. eng.
37. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011 Feb, 69(2):292-302. PubMed PMID: 21387374. Pubmed Central PMCID: 3084507. Epub 2011/03/10. eng.
38. Barkhof F., Filippi M., Miller D.H., Scheltens P., Campi A., Polman C.H., et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997 Nov, 120(Pt 11):2059-2069. PubMed PMID: 9397021. Epub 1997/12/16. eng.
39. Tintore M., Rovira A., Rio J., Nos C., Grive E., Sastre-Garriga J., et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003 Jan 14, 60(1):27-30. PubMed PMID: 12525713. Epub 2003/01/15. eng.
40. Dalton C.M., Brex P.A., Miszkiel K.A., Hickman S.J., MacManus D.G., Plant G.T., et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002 Jul, 52(1):47-53. PubMed PMID: 12112046. Epub 2002/07/12. eng.
41. Polman C., Barkhof F., Sandberg-Wollheim M., Linde A., Nordle O., Nederman T. Treatment with laquinimod reduces development of active MRI lesions in relapsing MS. Neurology 2005 Mar 22, 64(6):987-991. PubMed PMID: 15781813. Epub 2005/03/23. eng.
42. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005 Dec, 58(6):840-846. PubMed PMID: 16283615. Epub 2005/11/12. eng.
43. Swanton J.K., Rovira A., Tintore M., Altmann D.R., Barkhof F., Filippi M., et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007 Aug, 6(8):677-686. PubMed PMID: 17616439. Epub 2007/07/10. eng.
44. Swanton J.K., Fernando K., Dalton C.M., Miszkiel K.A., Thompson A.J., Plant G.T., et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. JNeurol Neurosurg Psychiatr 2006 Jul, 77(7):830-833. PubMed PMID: 16043456. Pubmed Central PMCID: 2117493. Epub 2005/07/27. eng.
45. Montalban X., Tintore M., Swanton J., Barkhof F., Fazekas F., Filippi M., et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology 2010 Feb 2, 74(5):427-434. PubMed PMID: 20054006. Epub 2010/01/08. eng.
46. Rovira A., Pericot I., Alonso J., Rio J., Grive E., Montalban X. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. AJNR Am J Neuroradiol 2002, 23(12063231):989-994.
47. Rovira A., Swanton J., Tintore M., Huerga E., Barkhof F., Filippi M., et al. Asingle, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol 2009 May, 66(5):587-592. PubMed PMID: 19433658. Epub 2009/05/13. eng.
48. Mowry E.M., Pesic M., Grimes B., Deen S.R., Bacchetti P., Waubant E. Clinical predictors of early second event in patients with clinically isolated syndrome. JNeurol 2009 Jul, 256(7):1061-1066. PubMed PMID: 19252775. Pubmed Central PMCID: 2708331. Epub 2009/03/03. eng.
49. West T., Wyatt M., High A., Bostrom A., Waubant E. Are initial demyelinating event recovery and time to second event under differential control?. Neurology 2006 Sep 12, 67(5):809-813. PubMed PMID: 16966542. Epub 2006/09/13. eng.
50. Achiron A., Barak Y. Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study. Arch Neurol 2000 Jul, 57(7):974-979. PubMed PMID: 10891979. Epub 2000/07/13. eng.
51. Comi G., Filippi M., Barkhof F., Durelli L., Edan G., Fernandez O., et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001 May 19, 357(9268):1576-1582. PubMed PMID: 11377645. Epub 2001/05/30. eng.
52. Di Pauli F., Reindl M., Ehling R., Schautzer F., Gneiss C., Lutterotti A., et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler 2008 Sep, 14(8):1026-1030. PubMed PMID: 18632775. Epub 2008/07/18. eng.
53. Lunemann J.D., Tintore M., Messmer B., Strowig T., Rovira A., Perkal H., et al. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol 2010 Feb, 67(2):159-169. PubMed PMID: 20225269. Pubmed Central PMCID: 2848293. Epub 2010/03/13. eng.
54. Rudick R.A., Cutter G. MRI lesions: a surrogate for relapses in multiple sclerosis?. Lancet Neurol 2013 Jul, 12(7):628-630. PubMed PMID: 23743083. Epub 2013/06/08. eng.
55. Jacobs L., Kinkel P.R., Kinkel W.R. Impact of nuclear magnetic resonance imaging on the assessment of multiple sclerosis patients. Semin Neurol 1986 Mar, 6(1):24-32. PubMed PMID: 3503355. Epub 1986/03/01. eng.
56. Ormerod I.E., Miller D.H., McDonald W.I., du Boulay E.P., Rudge P., Kendall B.E., et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain 1987 Dec, 110(Pt 6):1579-1616. PubMed PMID: 3427402. Epub 1987/12/01. eng.
57. Dalton C.M., Chard D.T., Davies G.R., Miszkiel K.A., Altmann D.R., Fernando K., et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004 May, 127(Pt 5):1101-1107. PubMed PMID: 14998914. Epub 2004/03/05. eng.
58. O'Riordan J.I., Thompson A.J., Kingsley D.P., MacManus D.G., Kendall B.E., Rudge P., et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 1998 Mar, 121(Pt 3):495-503. PubMed PMID: 9549525. Epub 1998/04/29. eng.
59. Isaac C., Li D.K., Genton M., Jardine C., Grochowski E., Palmer M., et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 1988 Oct, 38(10):1511-1515. PubMed PMID: 3419593. Epub 1988/10/01. eng.
60. Kappos L., Stadt D., Ratzka M., Keil W., Schneiderbanger-Grygier S., Heitzer T., et al. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology 1988, 30(4):299-302. PubMed PMID: 3050587. Epub 1988/01/01. eng.
61. Willoughby E.W., Grochowski E., Li D.K., Oger J., Kastrukoff L.F., Paty D.W. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 1989 Jan, 25(1):43-49. PubMed PMID: 2913928. Epub 1989/01/01. eng.
62. Brex P.A., Ciccarelli O., O'Riordan J.I., Sailer M., Thompson A.J., Miller D.H. Alongitudinal study of abnormalities on MRI and disability from multiple sclerosis. NEngl J Med 2002 Jan 17, 346(3):158-164. PubMed PMID: 11796849. Epub 2002/01/18. eng.
63. Frohman E.M., Goodin D.S., Calabresi P.A., Corboy J.R., Coyle P.K., Filippi M., et al. The utility of MRI in suspected MS: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2003 Sep 9, 61(5):602-611. PubMed PMID: 12963748. Epub 2003/09/10. eng.
64. Ghezzi A., Martinelli V., Torri V., Zaffaroni M., Rodegher M., Comi G., et al. Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. JNeurol 1999 Sep, 246(9):770-775. PubMed PMID: 10525973. Epub 1999/10/20. eng.
65. Miller D.H., Ormerod I.E., McDonald W.I., MacManus D.G., Kendall B.E., Kingsley D.P., et al. The early risk of multiple sclerosis after optic neuritis. JNeurol Neurosurg Psychiatr 1988 Dec, 51(12):1569-1571. PubMed PMID: 3221224. Pubmed Central PMCID: 1032775. Epub 1988/12/01. eng.
66. Morrissey S.P., Miller D.H., Kendall B.E., Kingsley D.P., Kelly M.A., Francis D.A., et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain 1993 Feb, 116(Pt 1):135-146. PubMed PMID: 8453454. Epub 1993/02/01. eng.
67. Simon J.H., Li D., Traboulsee A., Coyle P.K., Arnold D.L., Barkhof F., et al. Standardized MR imaging protocol for multiple sclerosis: consortium of MS centers consensus guidelines. AJNR Am J Neuroradiol 2006 Feb, 27(2):455-461. PubMed PMID: 16484429. Epub 2006/02/18. eng.
68. Beck R.W., Trobe J.D., Moke P.S., Gal R.L., Xing D., Bhatti M.T., et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 2003 Jul, 121(7):944-949. PubMed PMID: 12860795. Epub 2003/07/16. eng.
69. Minneboo A., Barkhof F., Polman C.H., Uitdehaag B.M., Knol D.L., Castelijns J.A. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 2004 Feb, 61(2):217-221. PubMed PMID: 14967769. Epub 2004/02/18. eng.
70. Scott T.F., Kassab S.L., Singh S. Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler 2005 Aug, 11(4):373-377. PubMed PMID: 16042216. Epub 2005/07/27. eng.
71. Zivadinov R., Cox J.L. Neuroimaging in multiple sclerosis. Int Rev Neurobiol 2007, 79:449-474. PubMed PMID: 17531854. Epub 2007/05/29. eng.
72. Cordonnier C., de Seze J., Breteau G., Ferriby D., Michelin E., Stojkovic T., et al. Prospective study of patients presenting with acute partial transverse myelopathy. JNeurol 2003 Dec, 250(12):1447-1452. PubMed PMID: 14673577. Epub 2003/12/16. eng.
73. Kruit M.C., van Buchem M.A., Hofman P.A., Bakkers J.T., Terwindt G.M., Ferrari M.D., et al. Migraine as a risk factor for subclinical brain lesions. JAm Med Assoc 2004 Jan 28, 291(4):427-434. PubMed PMID: 14747499. Epub 2004/01/30. eng.
74. Morris Z., Whiteley W.N., Longstreth W.T., Weber F., Lee Y.C., Tsushima Y., et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2009, 339:b3016. PubMed PMID: 19687093. Pubmed Central PMCID: 2728201. Epub 2009/08/19. eng.
75. Vernooij M.W., Ikram M.A., Tanghe H.L., Vincent A.J., Hofman A., Krestin G.P., et al. Incidental findings on brain MRI in the general population. NEngl J Med 2007 Nov 1, 357(18):1821-1828. PubMed PMID: 17978290. Epub 2007/11/06. eng.
76. Roemer S.F., Scheithauer B.W., Varnavas G.G., Lucchinetti C.F. Tumefactive demyelination and glioblastoma: a rare collision lesion. Clin Neuropathol 2011, 30(4):186-191. PubMed PMID: 21726504. Epub 2011/07/06. eng.
77. Calabrese M., Filippi M., Gallo P. Cortical lesions in multiple sclerosis. Nat Rev Neurol 2010, 6(8):438-444. PubMed PMID: 20625376. Epub 2010/07/14. eng.
78. Lucchinetti C.F., Popescu B.F., Bunyan R.F., Moll N.M., Roemer S.F., Lassmann H., et al. Inflammatory cortical demyelination in early multiple sclerosis. NEngl J Med 2011, 365(23):2188-2197. PubMed PMID: 22150037. Pubmed Central PMCID: 3282172. Epub 2011/12/14. eng.
79. Calabrese M., De Stefano N., Atzori M., Bernardi V., Mattisi I., Barachino L., et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007, 64(10):1416-1422. PubMed PMID: 17923625. Epub 2007/10/10. eng.
80. Nelson F., Poonawalla A.H., Hou P., Huang F., Wolinsky J.S., Narayana P.A. Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol 2007, 28(9):1645-1649. PubMed PMID: 17885241. Epub 2007/09/22. eng.
81. Hasan K.M., Narayana P.A. Magnetic resonance imaging-based quantitative iron mapping at 7-tesla remains to be elusive in multiple sclerosis. Ann Neurol 2009, 66(6):867. author reply PubMed PMID: 20035512. Epub 2009/12/26. eng.
82. Hammond K.E., Metcalf M., Carvajal L., Okuda D.T., Srinivasan R., Vigneron D., et al. Quantitative invivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008, 64(6):707-713. PubMed PMID: 19107998. Epub 2008/12/25. eng.
83. Kangarlu A., Bourekas E.C., Ray-Chaudhury A., Rammohan K.W. Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. AJNR Am J Neuroradiol 2007, 28(2):262-266. PubMed PMID: 17296991. Epub 2007/02/14. eng.
84. Mainero C., Benner T., Radding A., van der Kouwe A., Jensen R., Rosen B.R., et al. Invivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 2009, 73(12):941-948. PubMed PMID: 19641168. Pubmed Central PMCID: 2754332. Epub 2009/07/31. eng.
85. Calabrese M., Rocca M.A., Atzori M., Mattisi I., Favaretto A., Perini P., et al. A3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 2010, 67(3):376-383. PubMed PMID: 20373349. Epub 2010/04/08. eng.
86. Filippi M., Rocca M.A., Calabrese M., Sormani M.P., Rinaldi F., Perini P., et al. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology 2010, 75(22):1988-1994. PubMed PMID: 21115953. Epub 2010/12/01. eng.
87. Wattjes M.P., Harzheim M., Lutterbey G.G., Bogdanow M., Schild H.H., Traber F. High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria. JNeurol 2008, 255(1):56-63. PubMed PMID: 18080854. Epub 2007/12/18. eng.
88. Filippi M., Inglese M., Rovaris M., Sormani M.P., Horsfield P., Iannucci P.G., et al. Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study. Neurology 2000, 55(7):940-946. PubMed PMID: 11061248. Epub 2000/11/04. eng.
89. Iannucci G., Tortorella C., Rovaris M., Sormani M.P., Comi G., Filippi M. Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. AJNR Am J Neuroradiol 2000, 21(6):1034-1038. PubMed PMID: 10871009. Epub 2000/06/28. eng.
90. Wattjes M.P., Harzheim M., Lutterbey G.G., Hojati F., Simon B., Schmidt S., et al. Does high field MRI allow an earlier diagnosis of multiple sclerosis?. JNeurol 2008, 255(8):1159-1163. PubMed PMID: 18446305. Epub 2008/05/01. eng.
91. Rot U., Mesec A. Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis. Clin Neurol Neurosurg 2006, 108(3):271-274. PubMed PMID: 16378679. Epub 2005/12/28. eng.
92. Bradley W.G., Daroff R.B., Fenichel G.M., Jankovic J., Mazziotta J.C. Neurology in clinical practice. Clinical neurophysiology: electroencephalography and evoked potentials 2008, Elseiver Inc, Philadelphia, PA. 5th ed.
93. Pelayo R., Montalban X., Minoves T., Moncho D., Rio J., Nos C., et al. Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?. Mult Scler 2010, 16(1):55-61. PubMed PMID: 19995838. Epub 2009/12/10. eng.
94. Avasarala J.R., Cross A.H., Trotter J.L. Oligoclonal band number as a marker for prognosis in multiple sclerosis. Arch Neurol 2001, 58(12):2044-2045. PubMed PMID: 11735778. Epub 2001/12/26. eng.
95. Awad A., Hemmer B., Hartung H.P., Kieseier B., Bennett J.L., Stuve O. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis. JNeuroimmunol 2010, 219(1-2):1-7. PubMed PMID: 19782408. Epub 2009/09/29. eng.
96. Paolino E., Fainardi E., Ruppi P., Tola M.R., Govoni V., Casetta I., et al. Aprospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis. JNeurol Neurosurg Psychiatr 1996, 60(5):572-575. PubMed PMID: 8778266. Pubmed Central PMCID: 486374. Epub 1996/05/01. eng.
97. Polman C., Kappos L., Freedman M.S., Edan G., Hartung H.P., Miller D.H., et al. Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b. JNeurol 2008, 255(4):480-487. PubMed PMID: 18004635. Epub 2007/11/16. eng.
98. Sastre-Garriga J., Tintore M., Rovira A., Grive E., Pericot I., Comabella M., et al. Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings. Mult Scler 2003, 9(1):39-43. PubMed PMID: 12617267. Epub 2003/03/06. eng.
99. Tintore M., Rovira A., Brieva L., Grive E., Jardi R., Borras C., et al. Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS. Mult Scler 2001, 7(6):359-363. PubMed PMID: 11795456. Epub 2002/01/25. eng.
100. Zipoli V., Hakiki B., Portaccio E., Lolli F., Siracusa G., Giannini M., et al. The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis. Mult Scler 2009, 15(4):472-478. PubMed PMID: 19153171. Epub 2009/01/21. eng.
101. Freedman M.S., Thompson E.J., Deisenhammer F., Giovannoni G., Grimsley G., Keir G., et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 2005, 62(6):865-870. PubMed PMID: 15956157. Epub 2005/06/16. eng.
102. Link H., Huang Y.M. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. JNeuroimmunol 2006, 180(1-2):17-28. PubMed PMID: 16945427. Epub 2006/09/02. eng.
103. Masjuan J., Alvarez-Cermeno J.C., Garcia-Barragan N., Diaz-Sanchez M., Espino M., Sadaba M.C., et al. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology 2006, 66(4):576-578. PubMed PMID: 16505315. Epub 2006/03/01. eng.
104. Tintore M., Rovira A., Rio J., Tur C., Pelayo R., Nos C., et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?. Neurology 2008, 70(13 Pt 2):1079-1083. PubMed PMID: 17881717. Epub 2007/09/21. eng.
105. Martino D., Branson J.A., Church A.J., Candler P.M., Livrea P., Giovannoni G., et al. Soluble adhesion molecules in acute disseminated encephalomyelitis. Pediatr Neurol 2005, 33(16194723):255-258.
106. Trapp B.D., Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu Rev Neurosci 2008, 31:247-269. PubMed PMID: 18558855. Epub 2008/06/19. eng.
107. Hawa M., Beyan H., Leslie R.D. Principles of autoantibodies as disease-specific markers. Autoimmunity 2004, 37(4):253-256. PubMed PMID: 15518036. Epub 2004/11/03. eng.
108. Prince H.E. Biomarkers for diagnosing and monitoring autoimmune diseases. Biomarkers 2005, 10(Suppl.1):S44-S49. PubMed PMID: 16298911. Epub 2005/11/22. eng.
109. Schwarz M., Spector L., Gortler M., Weisshaus O., Glass-Marmor L., Karni A., et al. Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis. JNeurol Sci 2006, 244(1-2):59-68. PubMed PMID: 16480743. Epub 2006/02/17. eng.
110. Freedman M.S., Laks J., Dotan N., Altstock R.T., Dukler A., Sindic C.J. Anti-alpha-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event. Mult Scler 2009, 15(4):422-430. PubMed PMID: 19324980. Pubmed Central PMCID: 2850589. Epub 2009/03/28. eng.
111. Brettschneider J., Jaskowski T.D., Tumani H., Abdul S., Husebye D., Seraj H., et al. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases. JNeuroimmunol 2009, 217(1-2):95-101. PubMed PMID: 19879655. Epub 2009/11/03. eng.
112. Rudick R.A., Polman C.H. Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis. Lancet Neurol 2009, 8(6):545-559. PubMed PMID: 19446274. Epub 2009/05/19. eng.
113. Rudick R.A., Cohen J.A., Weinstock-Guttman B., Kinkel R.P., Ransohoff R.M. Management of multiple sclerosis. NEngl J Med 1997, 337(22):1604-1611. PubMed PMID: 9371858. Epub 1997/11/27. eng.
114. Jacobs L.D., Beck R.W., Simon J.H., Kinkel R.P., Brownscheidle C.M., Murray T.J., et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. NEngl J Med 2000, 343(13):898-904. PubMed PMID: 11006365. Epub 2000/09/28. eng.
115. Kappos L., Freedman M.S., Polman C.H., Edan G., Hartung H.P., Miller D.H., et al. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 2007, 370(9585):389-397. PubMed PMID: 17679016. Epub 2007/08/07. eng.
116. Berger T., Rubner P., Schautzer F., Egg R., Ulmer H., Mayringer I., et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. NEngl J Med 2003, 349(2):139-145. PubMed PMID: 12853586. Epub 2003/07/11. eng.
117. Tomassini V., De Giglio L., Reindl M., Russo P., Pestalozza I., Pantano P., et al. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Mult Scler 2007, 13(9):1086-1094. PubMed PMID: 17468447. Epub 2007/05/01. eng.
118. Greeve I., Sellner J., Lauterburg T., Walker U., Rosler K.M., Mattle H.P. Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort. Acta Neurol Scand 2007, 116(4):207-210. PubMed PMID: 17824895. Epub 2007/09/11. eng.
119. Lim E.T., Berger T., Reindl M., Dalton C.M., Fernando K., Keir G., et al. Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis. Mult Scler 2005, 11(4):492-494. PubMed PMID: 16042235. Epub 2005/07/27. eng.
120. Kuhle J., Lindberg R.L., Regeniter A., Mehling M., Hoffmann F., Reindl M., et al. Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF. JNeurol 2007, 254(2):160-168. PubMed PMID: 17334662. Epub 2007/03/06. eng.
121. Kuhle J., Pohl C., Mehling M., Edan G., Freedman M.S., Hartung H.P., et al. Lack of association between antimyelin antibodies and progression to multiple sclerosis. NEngl J Med 2007, 356(4):371-378. PubMed PMID: 17251533. Epub 2007/01/26. eng.
122. Pelayo R., Tintore M., Montalban X., Rovira A., Espejo C., Reindl M., et al. Antimyelin antibodies with no progression to multiple sclerosis. NEngl J Med 2007, 356(4):426-428. PubMed PMID: 17251547. Epub 2007/01/26. eng.
123. Teunissen C.E., Khalil M. Neurofilaments as biomarkers in multiple sclerosis. Mult Scler 2012, 18(5):552-556. PubMed PMID: 22492131. Epub 2012/04/12. eng.
124. Teunissen C.E., Iacobaeus E., Khademi M., Brundin L., Norgren N., Koel-Simmelink M.J., et al. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis. Neurology 2009, 72(15):1322-1329. PubMed PMID: 19365053. Epub 2009/04/15. eng.
125. Fialova L., Bartos A., Svarcova J., Zimova D., Kotoucova J., Malbohan I. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis. JNeuroimmunol 2013, 262(1-2):113-120. PubMed PMID: 23870535. Epub 2013/07/23. eng.
126. Fialova L., Bartos A., Svarcova J., Zimova D., Kotoucova J. Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis. JNeuroimmunol 2013, 259(1-2):81-87. PubMed PMID: 23632043. Epub 2013/05/02. eng.
127. Caldemeyer K.S., Smith R.R., Harris T.M., Edwards M.K. MRI in acute disseminated encephalomyelitis. Neuroradiology 1994, 36(8041443):216-220.
128. Dale R.C., de Sousa C., Chong W.K., Cox T.C., Harding B., Neville B.G. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000, 123(Pt 12):2407-2422. PubMed PMID: 11099444. Epub 2000/12/02. eng.
129. Mikaeloff Y., Caridade G., Husson B., Suissa S., Tardieu M. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol 2007, 11(17188007):90-95.
130. Murthy S.N.K., Faden H.S., Cohen M.E., Bakshi R. Acute disseminated encephalomyelitis in children. Pediatrics 2002, 110(12165620).
131. Tardieu M., Mikaeloff Y. What is acute disseminated encephalomyelitis (ADEM)?. Eur J Paediatr Neurol 2004, 8(15341905):239-242.
132. Rosman N.P., Gottlieb S.M., Bernstein C.A. Acute hemorrhagic leukoencephalitis: recovery and reversal of magnetic resonance imaging findings in a child. JChild Neurol 1997, 12(9373802):448-454.
133. Wong A.M., Simon E.M., Zimmerman R.A., Wang H.S., Toh C.H., Ng S.H. Acute necrotizing encephalopathy of childhood: correlation of MR findings and clinical outcome. AJNR Am J Neuroradiol 2006, 27(17032866):1919-1923.
134. D'Alessandro R., Vignatelli L., Lugaresi A., Baldin E., Granella F., Tola M.R., et al. Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study. J Neurol 2013, 260(6):1583-1593. Epub 2013 Feb 3. 10.1007/s00415-013-6838-x.